Literature DB >> 9192828

A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region.

M Zelada-Hedman1, B Wasteson Arver, A Claro, J Chen, B Werelius, H Kok, K Sandelin, S Håkansson, T I Andersen, A Borg, A L Børresen Dale, A Lindblom.   

Abstract

To identify BRCA1 germ-line mutations in the breast and breast-ovarian cancer families in the Stockholm region, a total of 127 families were screened. DNA from 174 patients from these families were studied using various mutation screening techniques, followed by direct DNA sequencing. Mutations were identified in 7 of 20 families with breast and ovarian cancer and in one family with ovarian cancer only, whereas only 1 family of 106 with breast cancer showed a mutation. Thus, germ-line mutations in BRCA1 were found in one-third of the families with both breast and ovarian cancer, but in only 1% of the breast cancer families. The low frequency of germ-line mutations in the site-specific breast cancer families means that other genes are likely to segregate in these families.

Entities:  

Mesh:

Year:  1997        PMID: 9192828

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.

Authors:  Sara Margolin; Hemming Johansson; Lars Erik Rutqvist; Annika Lindblom; Tommy Fornander
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

Review 2.  The genetics of inherited breast cancer.

Authors:  S A Gayther; P D Pharoah; B A Ponder
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

Review 3.  BRCA1/2 associated hereditary breast cancer.

Authors:  Li-song Teng; Yi Zheng; Hao-hao Wang
Journal:  J Zhejiang Univ Sci B       Date:  2008-02       Impact factor: 3.066

4.  Low frequency of E-cadherin alterations in familial breast cancer.

Authors:  S Salahshor; L Haixin; H Huo; V N Kristensen; N Loman; S Sjöberg-Margolin; A Borg ; A L Børresen-Dale; I Vorechovsky; A Lindblom
Journal:  Breast Cancer Res       Date:  2001-03-09       Impact factor: 6.466

5.  Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.

Authors:  Jingmei Li; Wei Xiong Wen; Martin Eklund; Anders Kvist; Mikael Eriksson; Helene Nordahl Christensen; Astrid Torstensson; Svetlana Bajalica-Lagercrantz; Alison M Dunning; Brennan Decker; Jamie Allen; Craig Luccarini; Karen Pooley; Jacques Simard; Leila Dorling; Douglas F Easton; Soo-Hwang Teo; Per Hall; Åke Borg; Henrik Grönberg; Kamila Czene
Journal:  Int J Cancer       Date:  2018-11-09       Impact factor: 7.396

6.  CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer.

Authors:  Sara Margolin; Hans Eiberg; Annika Lindblom; Marie Luise Bisgaard
Journal:  BMC Cancer       Date:  2007-08-17       Impact factor: 4.430

7.  Molecular genetics analysis of hereditary breast and ovarian cancer patients in India.

Authors:  Nagasamy Soumittra; Balaiah Meenakumari; Tithi Parija; Veluswami Sridevi; Karunakaran N Nancy; Rajaraman Swaminathan; Kamalalayam R Rajalekshmy; Urmila Majhi; Thangarajan Rajkumar
Journal:  Hered Cancer Clin Pract       Date:  2009-08-06       Impact factor: 2.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.